---
figid: PMC3845604__cjc-32-07-376-g001
figlink: /pmc/articles/PMC3845604/figure/cjc-32-07-376-g001/
number: F1
caption: PI3K-mTOR inhibitors induce PI3K-dependent and/or MYC-dependent resistance
  mechanisms to PI3K-mTOR-targeted therapy. Targeting the PI3K-mTOR pathway causes
  MYC activation through PDK1-dependent MYC phosphorylation and MYC amplification,
  which is parallel to PIK3CA-dependent AKT and MAPK activation, attenuating therapeutic
  effect of PI3K-mTOR inhibitors. PI3K, phosphatidylinositide 3-kinase; mTOR, mammalian
  target of rapamycin; PDK1, 3-phosphoinositide-dependent kinase 1; PI3KCA, phosphatidylinositol-4,5-bisphosphate
  3-kinase, catalytic subunit alpha; MAPK, mitogen-activated protein kinase.
pmcid: PMC3845604
papertitle: Molecular mechanisms of tumor resistance to PI3K-mTOR-targeted therapy.
reftext: Jing Tan, et al. Chin J Cancer. 2013 Jul;32(7):376-379.
pmc_ranked_result_index: '106802'
pathway_score: 0.9286975
filename: cjc-32-07-376-g001.jpg
figtitle: Mechanisms of resistance to PI3K-mTOR inhibitors in human cancer
year: '2013'
organisms: Homo sapiens
ndex: bea8a642-deb2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3845604__cjc-32-07-376-g001.html
  '@type': Dataset
  description: PI3K-mTOR inhibitors induce PI3K-dependent and/or MYC-dependent resistance
    mechanisms to PI3K-mTOR-targeted therapy. Targeting the PI3K-mTOR pathway causes
    MYC activation through PDK1-dependent MYC phosphorylation and MYC amplification,
    which is parallel to PIK3CA-dependent AKT and MAPK activation, attenuating therapeutic
    effect of PI3K-mTOR inhibitors. PI3K, phosphatidylinositide 3-kinase; mTOR, mammalian
    target of rapamycin; PDK1, 3-phosphoinositide-dependent kinase 1; PI3KCA, phosphatidylinositol-4,5-bisphosphate
    3-kinase, catalytic subunit alpha; MAPK, mitogen-activated protein kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - PIK3R5
  - MAPK12
  - PIK3R6
  - PDK1
  - MYC
  - AKT3
  - MAPK1
  - MAPKAP1
  - MAPK13
  - MAPK8
  - MAPK14
  - NRAS
  - RICTOR
  - PIK3CG
  - MAPK9
  - MLST8
  - KRAS
  - HRAS
  - PIK3R4
  - AKT1
  - MAPK10
  - PIK3CB
  - PIK3CD
  - MAPK11
  - MTOR
  - PIK3R3
  - PIK3CA
  - MAPK3
  - BEZ235
  - Rapamycin
  - Cancer
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K-dependent
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PI3K-dependent
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: MYC
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: (MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: (MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: PI3K-dependent
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: (MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K-dependent
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PI3K-dependent
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K-dependent
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: (MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K-dependent
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K-dependent
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
chemicals:
- word: BEZ235
  source: MESH
  identifier: C531198
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3845604__F1
redirect_from: /figures/PMC3845604__F1
figtype: Figure
---
